TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Depreciation & Amortization (CF) (2020 - 2026)

Updated

TScan Therapeutics (TCRX) posted Depreciation & Amortization (CF) of $678,000 for Q3 2026, down 11.6% from $767,000 a year earlier and down 3.0% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Depreciation & Amortization (CF) at TScan Therapeutics was $2.79 million, down 2.1% year-over-year; for FY2025, it came in at $2.9 million, down 29.3% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 19.3% (FY2020 to FY2025).
  • In prior years, TScan Therapeutics' Depreciation & Amortization (CF) was $4.1 million in FY2024 (-24.1%), $5.4 million in FY2023 (+5.9%), $5.1 million in FY2022 (+54.5%) and $3.3 million in FY2021 (+175.0%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $678,000 in Q1 2025 to a high of $1.5 million in Q1 2023 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in three of the last eight quarters, with an average decline of 20.1%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2021, with growth of 188.4%; the weakest was Q1 2025, with a decline of 45.9%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $699,000 (Q2 2026), $693,000 (Q1 2026) and $723,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 33,835.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 545.00 Mn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 2.12 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 192.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 726.00 Mn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 132.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - 678,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 678,000.00
Jun 30, 2026 699,000.00
Mar 31, 2026 693,000.00
Dec 31, 2025 723,000.00
Sep 30, 2025 767,000.00
Jun 30, 2025 698,000.00
Mar 31, 2025 678,000.00
Dec 31, 2024 711,000.00
Sep 30, 2024 1.03 Mn
Jun 30, 2024 1.12 Mn
Mar 31, 2024 1.25 Mn
Dec 31, 2023 1.28 Mn
Sep 30, 2023 1.29 Mn
Jun 30, 2023 1.30 Mn
Mar 31, 2023 1.50 Mn
Dec 31, 2022 1.48 Mn
Sep 30, 2022 1.25 Mn
Jun 30, 2022 1.21 Mn
Mar 31, 2022 1.20 Mn
Dec 31, 2021 1.14 Mn
API Access

TScan Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TCRX&period=max&api_key=YOUR_API_KEY